ABBOTT INDIA LIMITED

🇮🇳India
Ownership
Private
Established
1888-01-01
Employees
73K
Market Cap
$7.5B
Website
http://www.abbott.com

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

First Posted Date
2009-11-06
Last Posted Date
2012-09-10
Lead Sponsor
Abbott
Target Recruit Count
1035
Registration Number
NCT01009593
Locations
🇺🇸

Site Reference ID/Investigator# 24848, Honolulu, Hawaii, United States

🇺🇸

Site Reference ID/Investigator# 23609, Honolulu, Hawaii, United States

🇺🇸

Site Reference ID/Investigator# 23250, Louisville, Kentucky, United States

and more 160 locations

A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospinal Fluid

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-11-06
Last Posted Date
2010-12-14
Lead Sponsor
Abbott
Target Recruit Count
12
Registration Number
NCT01009216
Locations
🇺🇸

Site Reference ID/Investigator# 23882, Glendale, California, United States

Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children

First Posted Date
2009-11-03
Last Posted Date
2011-07-19
Lead Sponsor
Abbott
Target Recruit Count
100
Registration Number
NCT01006629
Locations
🇷🇺

Site Ref # / Investigator 22699, Ivanovo, Russian Federation

🇷🇺

Site Ref # / Investigator 24025, Moscow, Russian Federation

🇷🇺

Site Ref # / Investigator 15781, Moscow, Russian Federation

and more 16 locations

Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism

First Posted Date
2009-10-07
Last Posted Date
2011-07-11
Lead Sponsor
Abbott
Target Recruit Count
47
Registration Number
NCT00990704
Locations
🇯🇵

Site Ref # / Investigator 53789, Tokyo, Japan

🇯🇵

Site Ref # / Investigator 53793, Toyohashi, Japan

🇯🇵

Site Ref # / Investigator 53788, Yachiyo, Japan

and more 11 locations

Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-09-23
Last Posted Date
2010-10-21
Lead Sponsor
Abbott
Target Recruit Count
52
Registration Number
NCT00982826
Locations
🇺🇸

Site Reference ID/Investigator# 23742, Waukegan, Illinois, United States

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

First Posted Date
2009-09-15
Last Posted Date
2012-06-20
Lead Sponsor
Abbott
Target Recruit Count
272
Registration Number
NCT00977080
Locations
🇺🇸

Site Reference ID/Investigator# 22781, Tempe, Arizona, United States

🇺🇸

Site Reference ID/Investigator# 21144, St. Louis, Missouri, United States

🇺🇸

Site Reference ID/Investigator# 22770, Philadelphia, Pennsylvania, United States

and more 80 locations

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-08-31
Last Posted Date
2010-11-03
Lead Sponsor
Abbott
Target Recruit Count
28
Registration Number
NCT00968422
Locations
🇺🇸

Site Reference ID/Investigator# 23024, Orlando, Florida, United States

A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-08-17
Last Posted Date
2010-11-02
Lead Sponsor
Abbott
Target Recruit Count
8
Registration Number
NCT00959816
Locations
🇺🇸

Site Reference ID/Investigator# 22445, San Antonio, Texas, United States

Pharmacokinetic Study of ABT-126 in Healthy Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-08-14
Last Posted Date
2010-11-03
Lead Sponsor
Abbott
Target Recruit Count
20
Registration Number
NCT00959634
Locations
🇺🇸

Site Reference ID/Investigator# 22863, Austin, Texas, United States

Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-07-28
Last Posted Date
2010-10-21
Lead Sponsor
Abbott
Target Recruit Count
18
Registration Number
NCT00947440
Locations
🇺🇸

Site Reference ID/Investigator# 22384, Waukegan, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath